Biotech Funding Trends: Insights from Entrepreneurs and Investors
April 29, 2010 by biotechconnection.com · 1 Comment
Product DescriptionBased on interviews with dedicated biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding.
In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for [...]
Merck’s Millipore Bid May Leave Investors Waiting (Update3)
March 7, 2010 by biotechconnection.com · Leave a Comment
Merck’s Millipore Bid May Leave Investors Waiting (Update3)
March 2 (Bloomberg) — Merck KGaA’s $6 billion agreement to acquire Millipore Corp. , the U.S. supplier of equipment to biotechnology companies, may leave investors waiting longer for the “pure value creation” the German company promised three years ago when it bought Serono SA, analysts said.
Read more on [...]
Merck’s Millipore Bid May Leave Investors Waiting (Update2)
March 7, 2010 by biotechconnection.com · Leave a Comment
Merck’s Millipore Bid May Leave Investors Waiting (Update2)
March 2 (Bloomberg) — Merck KGaA’s $6 billion agreement to acquire Millipore Corp. , the U.S. supplier of equipment to biotechnology companies, may leave investors waiting longer for the “pure value creation” the German company promised three years ago when it bought Serono SA, analysts said.
Read more on [...]
Merck’s Millipore Bid May Leave Investors Waiting (Update4)
March 7, 2010 by biotechconnection.com · Leave a Comment
Merck’s Millipore Bid May Leave Investors Waiting (Update4)
March 2 (Bloomberg) — Merck KGaA’s $6 billion agreement to acquire Millipore Corp. , the U.S. supplier of equipment to biotechnology companies, may leave investors waiting longer for the “pure value creation” the German company promised three years ago when it bought Serono SA, analysts said.
Read more on [...]
Successful Biotech Investing: Every Investor’s Complete Guide
February 25, 2010 by biotechconnection.com · 5 Comments
Product DescriptionAs the adage goes, “Invest in what you know.” Many investors have made fortunes in biotech stocks and funds—a very lucrative but risky sector. If you don’t have a medical background, how can you make intelligent picks in biotechnology?
With Successful Biotech Investing, understanding the science and business behind biotechnology is easy. Financial and medical [...]
